BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Z, He L, Jia H, Huang Q, Chen D, Zhang Z. The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer. Iran J Basic Med Sci 2017;20:187-92. [PMID: 28293396 DOI: 10.22038/ijbms.2017.8246] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
Number Citing Articles
1 Bliemsrieder E, Kaissis G, Grashei M, Topping G, Altomonte J, Hundshammer C, Lohöfer F, Heid I, Keim D, Gebrekidan S, Trajkovic-Arsic M, Winkelkotte AM, Steiger K, Nawroth R, Siveke J, Schwaiger M, Makowski M, Schilling F, Braren R. Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC. Sci Rep 2021;11:1191. [PMID: 33441943 DOI: 10.1038/s41598-020-80952-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Yi Q, Xie W, Sun W, Sun W, Liao Y. A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis. J Cancer 2022;13:313-24. [PMID: 34976192 DOI: 10.7150/jca.64846] [Reference Citation Analysis]
3 Wei C, Gao JJ. Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis. PeerJ 2019;7:e7882. [PMID: 31637133 DOI: 10.7717/peerj.7882] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hu B, Gong Z, Bi Z. Inhibition of miR-383 suppresses oxidative stress and improves endothelial function by increasing sirtuin 1. Braz J Med Biol Res 2020;53:e8616. [PMID: 31994599 DOI: 10.1590/1414-431X20198616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cheng Y, Liu N, Yang C, Jiang J, Zhao J, Zhao G, Chen F, Zhao H, Li Y. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8. Mol Genet Genomic Med 2020;8:e1272. [PMID: 32441881 DOI: 10.1002/mgg3.1272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang J, Zhou Y, Fei X, Chen X, Chen Y. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p. Sci Rep 2018;8:11094. [PMID: 30038373 DOI: 10.1038/s41598-018-29271-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
7 De Matteis S, Ragusa A, Marisi G, De Domenico S, Casadei Gardini A, Bonafè M, Giudetti AM. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. Oxid Med Cell Longev 2018;2018:7512159. [PMID: 30524660 DOI: 10.1155/2018/7512159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
8 Li L, Zhao Z, Jiang W, Guo J, Zhang S. Identification and functional characterization of Lys-trimethylation of lactate dehydrogenase A. Onco Targets Ther 2019;12:5395-404. [PMID: 31371982 DOI: 10.2147/OTT.S208637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Tu C, Chen W, Wang S, Tan W, Guo J, Shao C, Wang W. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. J Cell Mol Med 2019;23:7190-9. [PMID: 30801960 DOI: 10.1111/jcmm.14197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
10 Bresesti C, Vezzoli V, Cangiano B, Bonomi M. Long Non-Coding RNAs: Role in Testicular Cancers. Front Oncol 2021;11:605606. [PMID: 33767982 DOI: 10.3389/fonc.2021.605606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Salazar J, Le A. The Heterogeneity of Liver Cancer Metabolism. Adv Exp Med Biol 2021;1311:127-36. [PMID: 34014539 DOI: 10.1007/978-3-030-65768-0_9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zhang HF, Wang YC, Han YD. MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism. Mol Med Rep 2018;17:4483-9. [PMID: 29328457 DOI: 10.3892/mmr.2018.8399] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
13 Jin Y, Wang Z, He D, Zhu Y, Chen X, Cao K. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med 2021;10:8693-707. [PMID: 34668665 DOI: 10.1002/cam4.4341] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pan Y, Hu GY, Jiang S, Xia SJ, Maher H, Lin ZJ, Mao QJ, Zhao J, Cai LX, Xu YH, Xu JJ, Cai XJ. Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma. Front Oncol 2021;11:637971. [PMID: 34094917 DOI: 10.3389/fonc.2021.637971] [Reference Citation Analysis]